Yuri Ueda

Otolaryngology Head And Neck Surgery
Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Anaplastic Thyroid Carcinoma With Cardiac Dysfunction Developed During Combination Therapy With Dabrafenib and Trametinib.

Anaplastic Thyroid Carcinoma With Cardiac Dysfunction Developed During Combination Therapy With Dabrafenib and Trametinib.

Journal: Cureus

Published: May 17, 2026

A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).

A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY).

Journal: Japanese journal of clinical oncology

Published: March 07, 2026

Pembrolizumab and Quality of Life in Recurrent or Metastatic Head and Neck Cancer.

Pembrolizumab and Quality of Life in Recurrent or Metastatic Head and Neck Cancer.

Journal: Anticancer research

Published: February 07, 2026

Non-surgical definitive treatment and geriatric assessment in older patients with locally advanced head and neck cancer.

Non-surgical definitive treatment and geriatric assessment in older patients with locally advanced head and neck cancer.

Journal: Japanese journal of clinical oncology

Published: January 31, 2026

Clinical Outcomes of Pembrolizumab in Head and Neck Squamous Cell Carcinoma Subsites Excluded from the KEYNOTE-048 Trial.

Clinical Outcomes of Pembrolizumab in Head and Neck Squamous Cell Carcinoma Subsites Excluded from the KEYNOTE-048 Trial.

Journal: Current oncology (Toronto, Ont.)

Published: December 17, 2025

Effectiveness of Pembrolizumab Monotherapy for Older Adults With Head and Neck Carcinoma by CPS Status.

Effectiveness of Pembrolizumab Monotherapy for Older Adults With Head and Neck Carcinoma by CPS Status.

Journal: Anticancer research

Published: December 16, 2025

Usefulness of Upfront Neck Dissection Before Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma.

Usefulness of Upfront Neck Dissection Before Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma.

Journal: In vivo (Athens, Greece)

Published: August 19, 2024

Effect of Nivolumab on the Quality of Life in Recurrent/Metastatic Head and Neck Cancer.

Effect of Nivolumab on the Quality of Life in Recurrent/Metastatic Head and Neck Cancer.

Journal: Anticancer research

Published: June 14, 2024

A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancers.

A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancers.

Journal: Japanese journal of clinical oncology

Published: April 14, 2024

Pregnancy and delivery in an advanced cancer survivor with immune checkpoint inhibitor-induced type 1 diabetes: a case report.

Pregnancy and delivery in an advanced cancer survivor with immune checkpoint inhibitor-induced type 1 diabetes: a case report.

Journal: Endocrine

Published: January 31, 2024

Maxillary Sinus NUT Carcinoma: A Case Report.

Maxillary Sinus NUT Carcinoma: A Case Report.

Journal: Cancer diagnosis & prognosis

Published: December 20, 2023

Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck.

Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck.

Journal: Frontiers in oncology

Published: May 12, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026